As the Human Genome Project research progresses, it is becoming increasingly possible to predict what diseases a person may be likely to develop, based solely on their genetic makeup. This capability brings about the possibility of detecting potentially fatal diseases in their early stages, therefore increasing the chances for a complete recovery. However, this same technology could also be used by Managed Care Organizations (MCOs) as a basis for increasing premiums or denying coverage. In order to alleviate this popular concern, we researched several debilitating diseases. We then assessed the feasibility of implementing standardized genetic testing for the targeted diseases in a way that would be economically efficient while maximizing the preventive care MCOs offer. Finally, we analyzed the impacts present and future legislation might have on genetic testing and managed care.
Learning Objectives: From listening to this presentation, participants should be able to: 1.Recognize the importance of early disease detection through the use of genetic testing. 2.Compare the costs of preventive care to emergency care in Managed Care Organizations (MCOs). 3.Apply the effects of State and Federal legislation against genetic discrimination to genetic testing in MCOs
Keywords: Genetics, Managed Care
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.